SureTrader Nadex Advertisement Interactive Brokers Advertisement SureTrader
Home > Boards > US Listed > Biotechs >

Celldex Therapeutics, Inc. (CLDX)

CLDX RSS Feed
Add CLDX Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 5/10/2017 12:03:28 PM - Followers: 101 - Board type: Free - Posts Today: 0

 

 

 Celldex Therapeutics, Inc. (CLDX)

 

slider-images-2

 slider-images-3
http://www.celldextherapeutics.com
 

 

 
Company Information:
Celldex Therapeutics, Inc.
222 Cameron Drive
Suite 400
Phillipsburg, NJ. 08865
Phone: 908-454-7120
Fax:  908-454-1911
 
CIK
0000744218
Celldex Therapeutics (NASDAQ: CLDX) was founded based on a fundamental scientific belief that harnessing the power of the immune system would break significant barriers in drug development for a host of devastating diseases. The Company’s pipeline is comprised of therapeutic antibodies, antibody drug conjugates, immune system modulators and vaccines that we believe have a higher probability of success because they are targeted to specific patient populations with high unmet medical need whose diseases express specific markers—including many underserved or completely un-served orphan indications. This has created a leading pipeline in immunotherapy comprised of two candidates in pivotal trials, one in brain cancer and one in triple negative breast cancer, four additional clinical candidates in a range of difficult-to-treat indications and a robust preclinical engine.
Many of our clinical programs seek to leverage the power of the immune system’s response by combining therapeutic approaches to maximize their potential. Key to this strategy is our ability to understand our own asset base while also identifying promising external technologies that will complement it. In 2005, Celldex was spun out of the New Jersey based biopharmaceutical company Medarex (now a subsidiary of the Bristol-Myers Squibb Company) and, in connection with this transaction, Celldex retains the rights to obtain exclusive commercial licenses to proprietary monoclonal antibodies raised against certain antigens utilizing the Medarex UltiMAb technology platform. Since its inception, Celldex has also acquired four companies, folding in three assets, and in-licensed/purchased an additional two assets. With the potential for positive results in ongoing late stage programs, the next stage in Celldex’s development is to become a fully-integrated commercial entity.
 
Management: 
http://www.celldextherapeutics.com/about/management.php
 
 
Product Pipeline: 
http://www.celldextherapeutics.com/pipeline/pipeline-overview.php
 
 
News and Press Releases: 
http://ir.celldextherapeutics.com/releases.cfm
 
http://finance.yahoo.com/q/h?s=CLDX+Headlines

 

November 1, 2016

yes Celldex Expands Antibody and Immuno-Oncology Portfolio with the Acquisition of Kolltan Pharmaceuticals yes

http://ir.celldex.com/releasedetail.cfm?ReleaseID=996743
 
 
Events and Presentations:
http://ir.celldextherapeutics.com/events.cfm
 
 
SEC Filings:
http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000744218&owner=exclude&count=40
 
 
Transfer Agent:
Computershare, Inc.
250 Royall Street
Canton, MA 02021
Phone: (US) 800-736-3001 / (Int’l) 781-575-2000
 
 
Share Structure:
See SEC filings
 
Investor Relations:
Sarah Cavanaugh
Vice President
Investor Relations & Corporate Communications
ir@celldextherapeutics.com


----------------------------------------------

November 1, 2016

yes Celldex Expands Antibody and Immuno-Oncology Portfolio with the Acquisition of Kolltan Pharmaceuticals yes

http://ir.celldex.com/releasedetail.cfm?ReleaseID=996743
 

yes November 8, 2016  yes

 



http://www.fool.com/investing/2016/11/07/premium-celldex-therapeutics-inc-q3-results.aspx?source=djc&utm_campaign=article&utm_medium=feed&utm_source=djc


From a financial standpoint, the biggest update from Celldex related to its cash position. The biotech reported cash, cash equivalents, and marketable securities totaling $203.2 million at the end of the third quarter. Celldex used $24 million in cash during the quarter. 

yesyesyesyesyesyesyesyesyesyesyesyesyesyes



--------------------------------------------
 

 
 

 

  


 

All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.

 

Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn't a sign of endorsement.

 

Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement: http://investorshub.advfn.com/boards/complex_terms.asp

 

 

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
CLDX
Current Price
Volume:
Bid Ask Day's Range
CLDX News: Celldex Therapeutics to Present Clinical Results at 2017 ASCO Annual Meeting 05/17/2017 05:01:00 PM
CLDX News: Amended Statement of Ownership (sc 13g/a) 05/10/2017 09:53:36 AM
CLDX News: Quarterly Report (10-q) 05/09/2017 04:09:05 PM
CLDX News: Current Report Filing (8-k) 05/09/2017 04:03:05 PM
CLDX News: Celldex Reports First Quarter 2017 Results 05/09/2017 04:01:00 PM
PostSubject
#1392   we are buyers! harry crumb 05/10/17 12:03:28 PM
#1391   Where's the bottom here Harry? Serious question. dropped cdaniel394 05/10/17 11:36:49 AM
#1390   "Financial guidance: Celldex believes that the cash, cash rayank 05/10/17 08:03:02 AM
#1389   Nice write up on 4/1/17 - https://www.fool.com/investing/2017/04/01/3-top-stocks rayank 04/03/17 01:21:39 PM
#1388   Thanks for the heads up as always! Got erehdogmai 03/30/17 09:35:22 AM
#1387   * * $CLDX Video Chart 03-29-17 * * ClayTrader 03/29/17 05:28:00 PM
#1386   Very nice. rayank 03/29/17 04:10:09 PM
#1385   Nice ride today. Most excitement we've seen in erehdogmai 03/29/17 01:07:31 PM
#1384   absolutely, been adding lots of cldx from these prices harry crumb 03/27/17 06:30:54 PM
#1383   Hi all, I'm new in this today. rayank 03/22/17 11:57:34 AM
#1382   I'm not Harry, however the upcoming Catalyst over Hypocrates 03/07/17 03:56:52 PM
#1381   Do you think is a buy yet Harry? cdaniel394 03/07/17 01:19:31 PM
#1380   Yikes, I guess the presentation today must have disappointed. Hypocrates 03/07/17 10:40:20 AM
#1379   Interesting movement the last several days. Great opportunities here. erehdogmai 03/06/17 02:42:35 PM
#1378   upcoming catalysts hopefully bring good news, everyone seems harry crumb 02/28/17 05:11:45 PM
#1377   Good to see you here Harry, what make REDEMPTIVE 02/26/17 11:48:41 AM
#1376   interesting things happening with cldx. looking good here harry crumb 02/24/17 02:16:32 AM
#1375   So what's going on ? 8k? Joeymc77 02/07/17 09:52:41 PM
#1374   So are you buying here at $3.61? Looks stockboy 01/04/17 05:20:59 AM
#1373   if good news comes out i agree, until harry crumb 12/13/16 12:12:40 PM
#1372   Seriously over sold! Shorts have been giving up REDEMPTIVE 12/12/16 01:27:13 PM
#1371   pipeline is extremely undervalued here by pps, very harry crumb 12/11/16 08:53:19 AM
#1370   Let's not forget CDX-011 this could be a REDEMPTIVE 11/23/16 11:56:49 AM
#1369   Healthy Pullback this morning, this thing is a MrSaintor 11/15/16 10:03:04 AM
#1368   Good to have you aboard, exciting times for MrSaintor 11/15/16 09:53:38 AM
#1367   We have held CLDX shares since MEDX days. north40000 11/15/16 08:58:44 AM
#1366   Thanks for the update North, YES huge news MrSaintor 11/14/16 07:14:04 PM
#1365   Attended SITC this past Saturday, 11/12/2016, and talked north40000 11/14/16 04:06:35 PM
#1364   Totally agree, even at these levels great price MrSaintor 11/14/16 02:35:16 PM
#1363   25 harry crumb 11/14/16 02:20:06 PM
#1362   Wow. Good luck to those who held. I erehdogmai 11/14/16 02:09:47 PM
#1361   Any ideas on the pps until year end? Locke1 11/14/16 01:40:14 PM
#1360   Welcome back Locke1 11/14/16 01:36:17 PM
#1359   now thats news, finally for cldx. glad we harry crumb 11/14/16 01:34:10 PM
#1358   Still room to load up, unfortunately I missed Locke1 11/14/16 01:06:59 PM
#1357   With this news and any other breaking news REDEMPTIVE 11/14/16 11:58:28 AM
#1356   Celldex Presents Data on New Product Candidate, CDX-1140, MrSaintor 11/14/16 10:17:12 AM
#1355   LOVE IT .. CDX-1140 !! Great news !! MrSaintor 11/14/16 10:16:24 AM
#1354   Yep oversold and great news last week !! MrSaintor 11/13/16 12:41:52 AM
#1353   Nice little move up this week. It was noretreat 11/11/16 08:49:40 PM
#1352   Buying up the Dips ! MrSaintor 11/11/16 03:17:03 PM
#1351   Celldex looks very promising with its new acquisition MrSaintor 11/11/16 03:16:48 PM
#1350   The whole Bio tech sector will be doing REDEMPTIVE 11/11/16 03:12:51 PM
#1349   This things a beast ! Chart looking good MrSaintor 11/11/16 11:47:24 AM
#1348   Good thing we all don't trade or invest REDEMPTIVE 11/09/16 03:52:45 PM
#1347   Broke $4 ... let's see another push to HallaDurg 11/09/16 10:05:18 AM
#1346   Nice Chart read, clay, thanks for your input. MrSaintor 11/08/16 04:35:06 PM
#1345   And not everyone day trades. This is clearly MrSaintor 11/08/16 04:29:39 PM
#1344   * * $CLDX Video Chart 11-08-16 * * ClayTrader 11/08/16 04:23:37 PM
#1343   Everyones got their own thoughts and strategy's. Moto260 11/08/16 03:29:51 PM
PostSubject